** Shares of biopharmaceutical company Ardelyx ARDX.O up 1.93% to $5.03
** Co appoints Sue Hohenleitner as chief financial officer, effective November 4
** Hohenleitner most recently served as the vice president and CFO of Johnson & Johnson Innovative Medicine North America
** Justin Renz, the current CFO, will continue in his role through co's Q3 10-Q filing
** YTD, the stock has fallen ~1%, including session's moves